These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12846815)

  • 1. Neoplastic development in plasma cells.
    Potter M
    Immunol Rev; 2003 Aug; 194():177-95. PubMed ID: 12846815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling reveals different pathways related to Abl and other genes that cooperate with c-Myc in a model of plasma cell neoplasia.
    Park ES; Shaughnessy JD; Gupta S; Wang H; Lee JS; Woo HG; Zhan F; Owens JD; Potter M; Janz S; Mushinski JF
    BMC Genomics; 2007 Aug; 8():302. PubMed ID: 17764563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma cell tumour progression in iMycEmu gene-insertion mice.
    Kim JS; Han SS; Park SS; McNeil N; Janz S
    J Pathol; 2006 May; 209(1):44-55. PubMed ID: 16482495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6 and MYC collaborate in plasma cell tumor formation in mice.
    Rutsch S; Neppalli VT; Shin DM; DuBois W; Morse HC; Goldschmidt H; Janz S
    Blood; 2010 Mar; 115(9):1746-54. PubMed ID: 20018915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extraosseous IL-6 transgenic mouse plasmacytoma sometimes lacks Myc-activating chromosomal translocation.
    McNeil N; Kim JS; Ried T; Janz S
    Genes Chromosomes Cancer; 2005 Jun; 43(2):137-46. PubMed ID: 15751044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenetic relation between monoclonal gammopathies of undetermined significance and multiple myeloma.
    Greipp PR; Lust JA
    Stem Cells; 1995 Aug; 13 Suppl 2():10-21. PubMed ID: 8520496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of p53 exacerbates multiple myeloma phenotype by facilitating the reprogramming of hematopoietic stem/progenitor cells to malignant plasma cells by MafB.
    Vicente-Dueñas C; González-Herrero I; García Cenador MB; García Criado FJ; Sánchez-García I
    Cell Cycle; 2012 Oct; 11(20):3896-900. PubMed ID: 22983007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the bcl-2 family of pro- and anti-apoptotic genes in multiple myeloma and normal plasma cells: regulation during interleukin-6(IL-6)-induced growth and survival.
    Spets H; Strömberg T; Georgii-Hemming P; Siljason J; Nilsson K; Jernberg-Wiklund H
    Eur J Haematol; 2002 Aug; 69(2):76-89. PubMed ID: 12366710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A transgenic mouse model of plasma cell malignancy shows phenotypic, cytogenetic, and gene expression heterogeneity similar to human multiple myeloma.
    Boylan KL; Gosse MA; Staggs SE; Janz S; Grindle S; Kansas GS; Van Ness BG
    Cancer Res; 2007 May; 67(9):4069-78. PubMed ID: 17483317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence of dysregulated oncogenes in primary plasma cells representing consecutive stages of myeloma pathogenesis: indications for different disease entities.
    Rasmussen T; Theilgaard-Mönch K; Hudlebusch HR; Lodahl M; Johnsen HE; Dahl IM
    Br J Haematol; 2003 Oct; 123(2):253-62. PubMed ID: 14531906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6 transgenic mouse model for extraosseous plasmacytoma.
    Kovalchuk AL; Kim JS; Park SS; Coleman AE; Ward JM; Morse HC; Kishimoto T; Potter M; Janz S
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1509-14. PubMed ID: 11805288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling multiple myeloma by AID-dependent conditional activation of MYC.
    Kuehl WM
    Cancer Cell; 2008 Feb; 13(2):85-7. PubMed ID: 18242508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations.
    Silva S; Kovalchuk AL; Kim JS; Klein G; Janz S
    Cancer Res; 2003 Dec; 63(24):8656-63. PubMed ID: 14695177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights in the clinical biology of multiple myeloma.
    Bataille R
    Semin Hematol; 1997 Jan; 34(1 Suppl 1):23-8. PubMed ID: 9122743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. bcl-2 expression in plasma cells from neoplastic gammopathies and reactive plasmacytosis: a comparative study.
    Miguel-García A; Orero T; Matutes E; Carbonell F; Miguel-Sosa A; Linares M; Tarín F; Herrera M; García-Talavera J; Carbonell-Ramón F
    Haematologica; 1998 Apr; 83(4):298-304. PubMed ID: 9592978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1.
    Jourdan M; De Vos J; Mechti N; Klein B
    Cell Death Differ; 2000 Dec; 7(12):1244-52. PubMed ID: 11175262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrovirus that expresses v-abl and c-myc oncogenes rapidly induces plasmacytomas.
    Largaespada DA; Kaehler DA; Mishak H; Weissinger E; Potter M; Mushinski JF; Risser R
    Oncogene; 1992 Apr; 7(4):811-9. PubMed ID: 1565479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma cell myeloma. I. A new concept of disease biology].
    Barlogi B; Epstein J; Selvaniagam P; Alexanian R
    Gematol Transfuziol; 1991 Aug; 36(8):29-35. PubMed ID: 1752407
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of BAX in plasma cell dyscrasias.
    Renner S; Weisz J; Krajewski S; Krajewska M; Reed JC; Lichtenstein A
    Clin Cancer Res; 2000 Jun; 6(6):2371-80. PubMed ID: 10873089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in malignant transformation of monoclonal gammopathy of undetermined significance.
    Adami F; Bortolin M; Lestani M; Chilosi M; Semenzato G
    Leuk Lymphoma; 2002 Aug; 43(8):1713-4. PubMed ID: 12400621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.